Clinical Trials Directory

Trials / Completed

CompletedNCT00010504

Acupuncture in Fibromyalgia

Pilot Study of Acupuncture in Fibromyalgia

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
Sponsor
National Center for Complementary and Integrative Health (NCCIH) · NIH
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Fibromyalgia is the second most common rheumatic disorder, affecting approximately 8-10 million persons in the U.S., and is characterized by widespread musculoskeletal pain and soft tissue tenderness upon examination. This study focuses on the use of acupuncture as a mode of therapy for fibromyalgia. The issues under examination are: 1) the optimal duration of treatment, 2) the independent and synergistic effects of needle placement and needle stimulation, and 3) appropriate control strategies. The proposal utilizes a randomized, blinded, sham-controlled design to achieve these aims. Subjects are randomly assigned to one of four groups: 1)active site with stimulation, 2) active site, without stimulation, 3) sham site with stimulation, and 4) sham site, without stimulation. All subjects will receive acupuncture at escalating frequency, beginning at once per week and ending at 3 times per week. This "forced titration" design allows for the detection of inter-subject differences in responsiveness to acupuncture, as well as the factors which may predict responsiveness (or lack thereof). Secondary goals of the study are to collect data on the mechanism, safety, and cost-effectiveness of acupuncture in fibromyalgia, and to determine the optimal outcome measures, for a full scale research clinical trial.

Conditions

Interventions

TypeNameDescription
PROCEDUREAcupuncture

Timeline

Start date
2000-08-01
Completion
2003-07-01
First posted
2001-02-05
Last updated
2008-03-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00010504. Inclusion in this directory is not an endorsement.